Pharmaceutical

Five things for pharma marketers to know: Tuesday, April 19, 2016

Five things for pharma marketers to know: Tuesday, April 19, 2016

Novartis CEO under pressure to restore investor confidence; Orexigen terminates obesity drug; startup invests in shaky cholesterol-drug class

Infographic: Better promotion of clinical trials

Infographic: Better promotion of clinical trials

Companies spend $2 billion per year recruiting patients for clinical trials. A survey of 702 adults, conducted from December 2015 to January 2016, points to a need for more awareness.

Levy joins PatientsLikeMe, bringing the analyst closer to the patient in latest career move

Levy joins PatientsLikeMe, bringing the analyst closer to the patient in latest career move

Monique Levy, who's spent more than a decade helping drugmakers understand technology shifts, has joined PatientsLikeMe, the online discussion platform for people with chronic illness.

Precision for Medicine acquires ACT Oncology

Precision for Medicine acquires ACT Oncology

The scientific services company expands its portfolio to include expertise in oncology clinical studies.

Five things for pharma marketers to know: Friday, March 11, 2016

Five things for pharma marketers to know: Friday, March 11, 2016

Valeant CEO reportedly tells staffers that the worst is behind them; Sanofi hires chief medical officer from Novartis; PhRMA CEO says pricing debate is misinformed

Right-to-Try Laws Take Sensible Approach to Reforming FDA Rules

Right-to-Try Laws Take Sensible Approach to Reforming FDA Rules

The regulator's reliance on double-blind, placebo-controlled trials with exhaustive inclusion and exclusion criteria is incompatible with today's precision medicine.

Sensors, technology open the door to new era for clinical trials

Sensors, technology open the door to new era for clinical trials

Welcome to the mobile era for clinical trials, in which phone and tablet technology promise to upend a costly and unwieldy process.

Five things for pharma marketers to know: Friday, March 4, 2016

Five things for pharma marketers to know: Friday, March 4, 2016

New PhRMA CEO issues policy strategy; study assess patient response to immuno-oncology drugs; Twitter may be an effective way to talk about clinical trials

Twitter, Facebook, Google execs examine regulatory limits for drugmakers

Twitter, Facebook, Google execs examine regulatory limits for drugmakers

Technology executives discussed how pharma companies can leverage social media to better engage with patients online.

How physician preference for mobile influences strategy

How physician preference for mobile influences strategy

Physicians like mobile and they prefer the iPhone to Android devices — and that knowledge is changing the way drugmakers promote their products online.